US (PA): Cresco Labs acquires three retail locations

Cresco Labs has acquired Cure, a company with three operational dispensaries in Lancaster, Phoenixville, and Philadelphia, Pennsylvania for $90 million.

"Our focus heading into 2022 is on tailoring our strategy to the dynamics of each state to maintain a dominant market position and increase profitability. Between the acquisition of Cure Penn and the pending acquisition of Laurel Harvest, we are adding four new operational stores, licenses for five incremental stores, and 52 thousand square feet of indoor cultivation space in Pennsylvania," said Charlie Bachtell, Cresco Labs’ CEO and Co-founder. 

"This acquisition is another example of our focus on strategic breadth, depth, and execution to the path to success today and as this industry evolves.